The Current Ratio as of June 2026 (TTM) for Entero Therapeutics, Inc. (ENTO) is 0.16

According to Entero Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.16. This represents a change of -88.93% compared to the average of 1.44 of the last 4 quarters.

Entero Therapeutics, Inc. (ENTO) Historical Current Ratio (quarterly & annually)

How has ENTO Current Ratio performed in the past?

The mean historical Current Ratio of Entero Therapeutics, Inc. over the last ten years is 1.19. The current 0.16 Current Ratio has changed 1.24% with respect to the historical average. Over the past ten years (40 quarters), ENTO's Current Ratio was at its highest in in the June 2024 quarter at 5.49. The Current Ratio was at its lowest in in the September 2016 quarter at 0.09.

Entero Therapeutics, Inc. (ENTO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Entero Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Entero Therapeutics, Inc. (ENTO) Average Current Ratio

How has ENTO Current Ratio performed in the past?

The current Current Ratio of Entero Therapeutics, Inc. (ENTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Entero Therapeutics, Inc. (ENTO) Current Ratio vs. Peers

How is ENTO’s Current Ratio compared to its peers?

Entero Therapeutics, Inc.’s Current Ratio is less than Curis, Inc. (1.00), less than Processa Pharmaceuticals, Inc. (0.98), less than BriaCell Therapeutics Corp. (7.07), less than Palisade Bio, Inc. (23.71), less than Citius Pharmaceuticals, Inc. (0.58), less than Leap Therapeutics, Inc. (27.28), less than Aspire Biopharma Holdings, Inc. (2.26), less than Athira Pharma, Inc. (10.38), less than Cingulate Inc. (2.55), less than Allarity Therapeutics, Inc. (1.23),

Build a custom stock screener for Entero Therapeutics, Inc. (ENTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entero Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Entero Therapeutics, Inc. (ENTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Entero Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.